Skip to main content

Cytek Biosciences, Inc.

corporate_fare Company Profile

Cytek Biosciences, Inc.

CTKB·NASDAQ·Industrial Applications And Services·CIK 0001831915

The company is a cell analysis solutions company that uses its patented Full Spectrum Profiling (FSP) technology. This technology leverages the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. The FSP technology optimizes sensitivity and accuracy through its optical and electronic designs, which use an innovative method of light detection and distribution to a specific number and type of detectors. This design allows researchers to collect the full range of light emissions in a compact space, leading to higher resolution. This enables the development of complex assays with 50 different colors (individual fluorochromes), supporting 50 biomarkers within a single tube. The company aims to be a premier cell analysis company by innovating tools for biomedical research and clinical applications. Single-cell analysis is crucial for understanding complex biological systems and identifying specific cells relevant to biological questions, which impacts drug development and healthcare. There is a demand for high-dimensional cell analysis solutions that provide a complete picture of cellular biological processes and interactions. Scientists need to phenotype and isolate rare events or unique populations at the single-cell level using highly resolvable multi-dimensional cell analysis. Conventional flow cytometry, mass cytometry, and early spectral flow cytometry technologies have faced challenges due to limited dimensionality, sub-optimal resolution, low throughput, high cost, or the need for significant technical expertise.

Cytek Biosciences, Inc. (NASDAQ:CTKB) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 14 items for CTKB at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-04, rated 7/10. Across its 14 most recent items scored 7 or higher, the top rating is 9/10, with 3 rated 8 or above. Recent SEC coverage for CTKB spans 10-Q, 8-K, 10-K.

Recent high-impact activity:

  • Cytek 10-Q: Q3 Net Loss Widens to $6.1M; New ITC and Delaware Suits Filed Against Beckman Coulter
  • Cytek Holds Guidance Midpoint as Gross Margin Jumps 590 bps, Revenue Up 2%
  • Cytek Hit With $56.1M Patent Verdict in Beckman Coulter Case
  • Cytek Biosciences Raises Full-Year Outlook Despite Slight Q2 Revenue Miss
  • Cytek Q2 Loss Deepens as Litigation Costs Surge Ahead of Trial

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$201.49M
Net Income
-$66.54M
Op. Cash Flow
-$4.69M
Free Cash Flow
-$8.77M
Gross Profit
$104.46M
Operating Income
-$40.38M
Cash & Equivalents
$90.85M
Debt / Equity
0.00×
Net Margin
-33.0%
Shares Outstanding
128.55M sh
Source: 10-K · filed 2026-02-26 · accession 0001628280-26-012352

Short Interest & Short Volume

3.56 days to cover

FINRA reported short interest of 4,105,921 shares in CTKB as of the October 30, 2026 settlement, a 6.9% decrease from the prior period — about 3.6 days to cover at its recent average daily volume. On November 20, 2026, 20.7% of CTKB volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)4,105,921 shares as of October 30, 2026
Change vs prior period▼ 6.9%
Days to cover3.56 at avg daily volume of 1,154,072
Daily short volume (FINRA facilities)20.7% of 753,501 shares on November 20, 2026
5-day average short volume29.6%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with C →
$6.12
52-week range · as of 2026-11-04 $3.31 – $6.33
Market cap
$800.4M
Volume
1.8M (1.4× avg)
3-mo avg 1.3M
Live data · 2026-11-22 03:53 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CTKB - Latest Insights

CTKB
Nov 04, 2026, 5:02 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $5.97
Real-time Price: $6.12 info
Change: +$0.1486 (+2%) info
Market Cap: $800.398M info
CTKB
Nov 04, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.88
Real-time Price: $6.12 info
Change: +$0.240 (+4%) info
Market Cap: $800.398M info
CTKB
Aug 24, 2026, 6:01 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.56
Real-time Price: $6.12 info
Change: +$1.56 (+34%) info
Market Cap: $800.398M info
CTKB
Aug 05, 2026, 5:10 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $4.20
Real-time Price: $6.12 info
Change: +$1.92 (+46%) info
Market Cap: $800.398M info
CTKB
Aug 05, 2026, 5:06 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $4.04
Real-time Price: $6.12 info
Change: +$2.08 (+52%) info
Market Cap: $800.398M info
CTKB
Aug 05, 2026, 4:22 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.20
Real-time Price: $6.12 info
Change: +$1.92 (+46%) info
Market Cap: $800.398M info
CTKB
Jun 02, 2026, 4:23 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $4.19
Real-time Price: $6.12 info
Change: +$1.93 (+46%) info
Market Cap: $800.398M info
CTKB
Jun 02, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.19
Real-time Price: $6.12 info
Change: +$1.93 (+46%) info
Market Cap: $800.398M info
CTKB
May 07, 2026, 5:03 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $4.20
Real-time Price: $6.12 info
Change: +$1.92 (+46%) info
Market Cap: $800.398M info
CTKB
May 07, 2026, 4:51 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $4.30
Real-time Price: $6.12 info
Change: +$1.82 (+42%) info
Market Cap: $800.398M info
CTKB
May 07, 2026, 4:14 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.20
Real-time Price: $6.12 info
Change: +$1.92 (+46%) info
Market Cap: $800.398M info
CTKB
Feb 26, 2026, 4:37 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $4.32
Real-time Price: $6.12 info
Change: +$1.80 (+42%) info
Market Cap: $800.398M info
CTKB
Feb 26, 2026, 4:17 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.49
Real-time Price: $6.12 info
Change: +$1.63 (+36%) info
Market Cap: $800.398M info
CTKB
Jan 13, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.70
Real-time Price: $6.12 info
Change: +$0.420 (+7%) info
Market Cap: $800.398M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets